TrialAmerican journal of hematology2014

Phase II study of pegylated liposomal doxorubicin, low-dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple myeloma.

Rachid C Baz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.